APA (7th ed.) Citation

K, A., S, K., A, S., H, K., A, M., T, I., . . . M, F. (2026). Association of tissue lymphocyte immunophenotype and clinical outcomes: A prospective study in patients with ulcerative colitis treated with vedolizumab. PloS one, 21(2), e0340271. https://doi.org/10.1371/journal.pone.0340271

Chicago Style (17th ed.) Citation

K, Ando, et al. "Association of Tissue Lymphocyte Immunophenotype and Clinical Outcomes: A Prospective Study in Patients with Ulcerative Colitis Treated with Vedolizumab." PloS One 21, no. 2 (2026): e0340271. https://doi.org/10.1371/journal.pone.0340271.

MLA (9th ed.) Citation

K, Ando, et al. "Association of Tissue Lymphocyte Immunophenotype and Clinical Outcomes: A Prospective Study in Patients with Ulcerative Colitis Treated with Vedolizumab." PloS One, vol. 21, no. 2, 2026, p. e0340271, https://doi.org/10.1371/journal.pone.0340271.